The iAβ5p β-breaker peptide regulates the Aβ(25-35) interaction with lipid bilayers through a cholesterol-mediated mechanism

Biochemical and Biophysical Research Communications

Volumn 417, Issue 1, 2012, Pages 88-92

  Vitiello, Giuseppe ^a,b   Grimaldi, Manuela ^c   D'Ursi, Anna Maria ^c   D'Errico, Gerardino ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CSGI Consorzio per lo Sviluppo dei Sistemi a Grande Interfase   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Amyloid; Sheet breaker; Cholesterol; Electron Spin Resonance; Lipid bilayer

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CHOLESTEROL; IABETA5P PROTEIN; PHOSPHOLIPID; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BETA SHEET; ELECTRON SPIN RESONANCE; HYDROPHOBICITY; LIPID BILAYER; LIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CHOLESTEROL; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; LIPID BILAYERS; PEPTIDE FRAGMENTS;

EID: 84855759411     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.061     Document Type: Article

References (36)

1. Hardy J.L., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
2. Murphy M.P., Hickman L.J., Eckman C.B., Uljon S.N., Wang R., Golde T.E. γ-Secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid β peptides of varying length. J. Biol. Chem. 1999, 274:11914-11923.
3. Vestergaard M., Kerman K., Masato S., Nagatani N., Takamura Y., Tamiya E. A rapid label-free electrochemical detection and kinetic study of Alzheimer's amyloid β aggregation. J. Am. Chem. Soc. 2005, 127:11892-11893.
4. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 1993, 13:1676-1687.
5. Seilheimer B., Bohrmann B., Bondolfi L., Muller F., Stuber D., Dobeli H. The toxicity of the Alzheimer's β-amyloid peptide correlates with a distinct fiber morphology. J. Struct. Biol. 1997, 119:59-71.
6. Standridge J.B. Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease. Curr. Alzheimer Res. 2006, 3:95-108.
7. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., Sabatini B.L. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA type glutamate receptor-dependent signaling pathway. J. Neurosci. 2007, 27:2866-2875.
8. Sciarretta K.L., Gordon D.J., Meredith S. Peptide-based inhibitors of amyloid assembly. Methods Enzymol. 2006, 413:273-312.
9. Soto C., Kindy M.S., Baumann M., Frangione B. Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation. Biochem. Biophys. Res. Commun. 1996, 226:672-680.
10. Soto C., Sigurdsson E.M., Morelli L., Kumar R.A., Castaño E.M., Frangione B. β-Sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat. Med. 1998, 4:822-826.
11. Soto C. Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease. Mol. Med. Today 1999, 5:343-350.
12. Adessi C., Soto C. Beta-sheet breaker strategy for the treatment of Alzheimer's disease. Drug Dev. Res. 2002, 56:184-193.
13. De Bona P., Giuffrida M.L., Caraci F., Copani A., Pignataro B., Attanasio F., Cataldo S., Pappalardo G., Rizzarelli E. Design and synthesis of new trehalose-conjugated pentapeptides as inhibitors of Aβ(1-42) fibrillogenesis and toxicity. J. Pept. Sci. 2009, 15:220-228.
14. Matsuzaki K. Physicochemical interactions of amyloid β-peptide with lipid bilayers. Biochim. Biophys. Acta 2007, 1768:1935-1942.
15. Gorbenko G.P., Kinnunen P.K. The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem. Phys. Lipids 2006, 141:72-82.
16. Vitiello G., Grimaldi M., Ramunno A., Ortona O., De Martino G., D'Ursi A.M., D'Errico G. Interaction of a β-sheet breaker peptide with lipid membranes. J. Pept. Sci. 2010, 16:115-122.
17. Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., Cotman C.W. Structure-activity analyses of β-amyloid peptides: contributions of the β 25-35 region to aggregation and neuro toxicity. J. Neurochem. 1995, 64:253-265.
18. D'Errico G., Vitiello G., Ortona O., Tedeschi A., Ramunno A., D'Ursi A.M. Interaction between Alzheimer's Aβ(25-35) peptide and phospholipid bilayers: the role of cholesterol. Biochim. Biophys. Acta 2008, 1778:2710-2716.
19. Calderon R.O., Attema B., DeVrie G.H. Lipid composition of neuronal cell bodies and neurites from cultured dorsal root ganglia. J. Neurochem. 1995, 64:424-429.
20. Marsh D., Watts A. Spin-labeling and lipid-protein interactions in membranes. Lipid-Protein Interactions 1982, vol. 2:53-126. Wiley Interscience, New York.
21. Marsh D. Electron spin resonance in membrane research: protein-lipid interactions. Methods 2008, 46:83-96.
22. Gordon L.M., Curtain C.C., Zhong Y.C., Kirkpatrick A., Mobley P.W., Waring A.J. The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation. Biochim. Biophys. Acta 1992, 1139:257-274.
23. Curtain C., Separovic F., Nielsen K., Craik D., Zhong Y., Kirkpatrick A. The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids. Eur. Biophys. J. 1999, 28:427-436.
24. Grimaldi M., Scrima M., Esposito C., Vitiello G., Ramunno A., Limongelli V., D'Errico G., Novellino E., D'Ursi A.M. Membrane charge dependent states of the β-amyloid fragment Aβ(16-35) with differently charged micelle aggregates. Biochim. Biophys. Acta 2010, 1798:660-671.
25. D'Errico G., D'Ursi A.M., Marsh D. Interaction of a peptide derived from glycoprotein gp36 of feline immunodeficiency virus and its lipoylated analogue with phospholipid membranes. Biochemistry 2008, 47:5317-5327.
26. D'Errico G., Vitiello G., D'Ursi A.M., Marsh D. Interaction of short modified peptides deriving from glycoprotein gp36 of feline immunodeficiency virus with phospholipid membranes. Eur. Biophys. J. 2009, 38:873-882.
27. Vitiello G., Falanga A., Galdiero M., Marsh D., Galdiero S., D'Errico G. Lipid composition modulates the interaction of peptides deriving from herpes simplex virus type I glycoproteins B and H with biomembranes. Biochim. Biophys. Acta 2011, 1808:2517-2526.
28. Marsh D., Horvath L.I. Structure, dynamics and composition of the lipid-protein interface. Perspectives from spin labelling. Biochim. Biophys. Acta 1998, 1376:267-296.
29. Marsh D. Protein modulation of lipids and vice versa in membranes. Biochim. Biophys. Acta 2008, 1778:1545-1575.
30. Davis J.H., Clair J.J., Juhasz J. Phase equilibria in DOPC/DPPC-d62/cholesterol mixtures. Biophys. J. 2009, 96:521-539.
31. Hubbell W., McConnell H.M. Molecular motion in spin-labelled phospholipids and membranes. J. Am. Chem. Soc. 1971, 93:314-326.
32. Gordon L.M., Sauerheber R.D. Studies on spin-labelled egg lecithin dispersions. Biochim. Biophys. Acta 1977, 466:34-43.
33. Gordon L.M., Curtain C.C. Electron spin resonance analysis of model and biological membranes. Advances in Membrane Fluidity 1: Methods for Studying Membrane Fluidity 1988, 25-89. Alan R. Liss, New York. R.C. Aloia, C.C. Curtain, L.M. Gordon (Eds.).
34. Galdiero S., Falanga A., Vitiello G., Vitiello M., Pedone C., D'Errico G., Galdiero M. Role of membranotropic sequences from herpes simplex virus type I glycoproteins B and H in the fusion process. Biochim. Biophys. Acta 2010, 1798:579-591.
35. Erilov D.A., Bartucci R., Guzzi R., Shubin A.A., Maryasov A.G., Marsh D., Dzuba S.A., Sportelli L. Water concentration profiles in membranes measured by ESEEM of spin-labeled lipids. J. Phys. Chem. B 2005, 109:12003-12013.
36. Bates I.R., Boggs J.M., Feix J.B., Harauz G. Membrane-anchoring and charge effects in the interaction of myelin basic protein with lipid bilayers studied by site-directed spin labelling. J. Biol. Chem. 2003, 278:29041-29047.